Avalyn, a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced the initiation of the AURA ...

In 1997, a cluster of similar cases emerged in Israel, affecting primarily young male countertop fabricators. When the link ...

Immunomodulatory approaches such as GRI-0621 (RARβγ agonist targeting iNKT activity) may support alveolar basement membrane repair and provide complementary biology for oral combination regimens.

While 80% of patients with pulmonary fibrosis find oxygen therapy beneficial, many face significant emotional and practical hurdles during initiation.

A new study published in The New England Journal of Medicine revealed that in idiopathic pulmonary fibrosis (IPF) inhaled ...

DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Please provide your email address to receive an email when new articles are posted on . Amy Hajari Case, MD, FCCP, looks forward to being chief medical officer during a time of “exciting” scientific ...

Results from the FIBRONEER-ILD trial showed nerandomilast significantly slowed lung function decline in patients with PPF compared with placebo. The Food and Drug Administration (FDA) has expanded the ...

In patients with CF, pre-transplant PH is associated with improved early post-transplant survival, but with poorer outcomes after 3 years.

The Crown Princess has not undertaken any engagements since Jan. 28 ...